Radiation dose to neuroanatomical structures of pituitary adenomas and the effect of Gamma Knife radiosurgery on pituitary function

Restricted access

OBJECTIVE

Gamma Knife radiosurgery (GKRS) provides a safe and effective management option for patients with all types of pituitary adenomas. The long-term adverse effects of targeted radiation to the hypothalamic-pituitary axis in relationship to radiation dose remain unclear. In this retrospective review, the authors investigated the role of differential radiation doses in predicting long-term clinical outcomes and pituitary function after GKRS for pituitary adenomas.

METHODS

A cohort of 236 patients with pituitary tumors (41.5% nonfunctioning, 58.5% functioning adenomas) was treated with GKRS between 1998 and 2015. Point dosimetric measurements, with no minimum volume, to 14 consistent points along the hypothalamus bilaterally, pituitary stalk, and normal pituitary were made. Statistical analyses were performed to determine the impact of doses to critical structures on clinical, radiological, and endocrine outcomes.

RESULTS

With a median follow-up duration of 42.9 months, 18.6% of patients developed new loss of pituitary function. The median time to endocrinopathy was 21 months (range 2–157 months). The median dose was 2.1 Gy to the hypothalamus, 9.1 Gy to the pituitary stalk, and 15.3 Gy to the normal pituitary. Increasing age (p = 0.015, HR 0.98) and ratio of maximum dose to the pituitary stalk over the normal pituitary gland (p = 0.013, HR 0.22) were independent predictors of new or worsening hypopituitarism in the multivariate analysis. Sex, margin dose, treatment volume, nonfunctioning adenoma status, or ratio between doses to the pituitary stalk and hypothalamus were not significant predictors.

CONCLUSIONS

GKRS offers a low rate of delayed pituitary insufficiency for pituitary adenomas. Doses to the hypothalamus are low and generally do not portend endocrine deficits. Patients who are treated with a high dose to the pituitary stalk relative to the normal gland are at higher risk of post-GKRS endocrinopathy. Point dosimetry to specific neuroanatomical structures revealed that a ratio of stalk-to-gland radiation dose of 0.8 or more significantly increased the risk of endocrinopathy following GKRS. Improvement in the gradient index toward the stalk and normal gland may help preserve endocrine function.

ABBREVIATIONS ACTH = adrenocorticotropic hormone; GH = growth hormone; GKRS = Gamma Knife radiosurgery; HP = hypothalamic-pituitary; IGF-1 = insulin-like growth factor–1; SRS = stereotactic radiosurgery; TSH = thyroid-stimulating hormone.

Article Information

Correspondence Jason P. Sheehan: University of Virginia, Charlottesville, VA. jsheehan@virginia.edu.

INCLUDE WHEN CITING Published online April 12, 2019; DOI: 10.3171/2019.1.JNS182296.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Studies of a 54-year-old man who originally presented with progressive decline of vision. Biochemical findings were consistent with the diagnosis of a nonfunctioning adenoma. The patient underwent pure endoscopic endonasal transsphenoidal resection. Following surgery, his vision problems improved, except for subtle deficits of the lower quadrant of the visual field. Serial imaging of the brain demonstrated substantial decompression of the optic chiasm, with a small residual tumor of the cavernous sinus on the right side. The patient then underwent GKRS 15 months after resection. All images are coronal sections of T1-weighted MR images with gadolinium contrast and fat suppression. A: Image obtained prior to resection showing a 2.5 × 2.1 × 2.6–cm sellar suprasellar homogeneously enhancing lesion with mass effect on the optic chiasm. B: Image obtained prior to GKRS. Note the enhancing soft tissue centered within the right cavernous sinus, measuring approximately 8 × 9 × 10 mm. C: Image obtained at the last follow-up demonstrating a decrease in the right cavernous sinus tissue compared with pretreatment examination. I = inferior; R = right.

  • View in gallery

    This is the same treatment scan acquired at the time of GKRS for the 54-year-old man featured in Fig. 1B. Point dosimetry showing where treatment measures were obtained along the hypothalamus, pituitary stalk, and pituitary gland. Fourteen distinct points along the HP axis were selected: 3 along both the left and right hypothalamus, 3 to the pituitary gland, and 5 to the pituitary stalk. LH = left hypothalamus; NP = normal pituitary; PS = pituitary stalk; RH = right hypothalamus. Figure is available in color online only.

  • View in gallery

    Cumulative endocrinopathy rate based on timing after GKRS. Using a multivariate analysis, there was a significant difference in the rate of endocrinopathy based on the ratio of maximum dose to the pituitary stalk over the normal pituitary gland, with a threshold of 0.8. Overall, 18.6% of patients developed endocrinopathy in a median of 21 months (range 2–157 months). Figure is available in color online only.

References

  • 1

    Attanasio REpaminonda PMotti EGiugni EVentrella LCozzi R: Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88:310531122003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Brada MRajan BTraish DAshley SHolmes-Sellors PJNussey S: The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38:5715781993

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Castro DGCecílio SACanteras MM: Radiosurgery for pituitary adenomas: evaluation of its efficacy and safety. Radiat Oncol 5:1092010

  • 4

    Cohen-Inbar ORamesh AXu ZVance MLSchlesinger DSheehan JP: Gamma knife radiosurgery in patients with persistent acromegaly or Cushing’s disease: long-term risk of hypopituitarism. Clin Endocrinol (Oxf) 84:5245312016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Cohen-Inbar OXu ZLee CCWu CCChytka TSilva D: Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study. J Neurooncol 135:67742017

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Cohen-Inbar OXu ZSchlesinger DVance MLSheehan JP: Gamma Knife radiosurgery for medically and surgically refractory prolactinomas: long-term results. Pituitary 18:8208302015

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Dekkers OMPereira AMRomijn JA: Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93:371737262008

  • 8

    Ezzat SAsa SLCouldwell WTBarr CEDodge WEVance ML: The prevalence of pituitary adenomas: a systematic review. Cancer 101:6136192004

  • 9

    Feigl GCBonelli CMBerghold AMokry M: Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97 (5 Suppl):4154212002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Feigl GCPistracher KBerghold AMokry M: Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. J Neurosurg 113 Suppl:1531592010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Gopalan RSchlesinger DVance MLLaws ESheehan J: Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery 69:2842932011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Graffeo CSLink MJBrown PDYoung WF JrPollock BE: Hypopituitarism after single-fraction pituitary adenoma radiosurgery: dosimetric analysis based on patients treated using contemporary techniques. Int J Radiat Oncol Biol Phys 101:6186232018

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Hayashi MChernov MTamura NNagai MYomo SOchiai T: Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases. J Neurooncol 98:1851942010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Hayashi MIzawa MHiyama HNakamura SAtsuchi SSato H: Gamma Knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg 72 (Suppl 1):1111181999

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Höybye CRähn T: Adjuvant Gamma Knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients. Pituitary 12:2112162009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Iwai YYamanaka KYoshioka K: Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery 56:6997052005

  • 17

    Iwata HSato KTatewaki KYokota NInoue MBaba Y: Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. Neuro Oncol 13:9169222011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Izawa MHayashi MNakaya KSatoh HOchiai THori T: Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 93 (Suppl 3):19222000

  • 19

    Jagannathan JSheehan JPPouratian NLaws ERSteiner LVance ML: Gamma Knife surgery for Cushing’s disease. J Neurosurg 106:9809872007

  • 20

    Kajiwara KSaito KYoshikawa KKato SAkimura TNomura S: Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas. Minim Invasive Neurosurg 48:91962005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Landolt AMLomax N: Gamma knife radiosurgery for prolactinomas. J Neurosurg 93 (Suppl 3):14182000

  • 22

    Langsenlehner TStiegler CQuehenberger FFeigl GCJakse GMokry M: Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther Onkol 183:2412472007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Liscák RVladyka VMarek JSimonová GVymazal J: Gamma knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir (Wien) 149:99910062007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Losa MValle MMortini PFranzin Ada Passano CFCenzato M: Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 100:4384442004

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Mingione VYen CPVance MLSteiner MSheehan JLaws ER: Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg 104:8768832006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Minniti GGilbert DCBrada M: Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord 10:1351442009

  • 27

    Minniti GJaffrain-Rea MLOsti MCantore GEnrici RM: Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev 30:1671762007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Mokry MRamschak-Schwarzer SSimbrunner JGanz JCPendl G: A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact Funct Neurosurg 72 (Suppl 1):881001999

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Park KJKano HParry PVNiranjan AFlickinger JCLunsford LD: Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery 69:118811992011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Park YGChang JWKim EYChung SS: Gamma knife surgery in pituitary microadenomas. Yonsei Med J 37:1651731996

  • 31

    Petrovich ZYu CGiannotta SLZee CSApuzzo ML: Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery 53:51612003

  • 32

    Picozzi PLosa MMortini PValle MAFranzin AAttuati L: Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg 102 Suppl:71742005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Pollock BECochran JNatt NBrown PDErickson DLink MJ: Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 70:132513292008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Pomeraniec IJDallapiazza RFXu ZJane JA JrSheehan JP: Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. J Neurosurg 125:2022122016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Sheehan JPKondziolka DFlickinger JLunsford LD: Radiosurgery for nonfunctioning pituitary adenoma. Neurosurg Focus 14(5):e92003

  • 36

    Sheehan JPKondziolka DFlickinger JLunsford LD: Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 97 (5 Suppl):4084142002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Sheehan JPNiranjan ASheehan JMJane JA JrLaws ERKondziolka D: Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:6786912005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Sheehan JPStarke RMMathieu DYoung BSneed PKChiang VL: Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg 119:4464562013

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Sicignano GLosa Mdel Vecchio ACattaneo GMPicozzi PBolognesi A: Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. Radiother Oncol 104:1191242012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Snell JWSheehan JStroila MSteiner L: Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg 104:1571622006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Sokolowski JDCohen-Inbar OSheehan JP: Radiosurgery for infundibulum adenoma: stalk dose implications. Acta Neurochir (Wien) 158:169717002016

  • 42

    Starke RMNguyen JHRainey JWilliams BJSherman JHSavage J: Gamma Knife surgery of meningiomas located in the posterior fossa: factors predictive of outcome and remission. J Neurosurg 114:139914092011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    Starke RMWilliams BJJane JA JrSheehan JP: Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J Neurosurg 117:1291352012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    Teramoto AHirakawa KSanno NOsamura Y: Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193:1611641994

  • 45

    Trifiletti DMXu ZDutta SWQuiñones-Hinojosa APeterson JVance ML: Endocrine remission after pituitary stereotactic radiosurgery: differences in rates of response for matched cohorts of Cushing Disease and acromegaly patients. Int J Radiat Oncol Biol Phys 101:6106172018

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Vance ML: Pituitary adenoma: a clinician’s perspective. Endocr Pract 14:7577632008

  • 47

    Vladyka VLiscák RNovotný J JrMarek JJezková J: Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52:3093172003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48

    Voges JKocher MRunge MPoggenborg JLehrke RLenartz D: Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107:135513642006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49

    Williams BJYen CPStarke RMBasina BNguyen JRainey J: Gamma Knife surgery for parasellar meningiomas: long-term results including complications, predictive factors, and progression-free survival. J Neurosurg 114:157115772011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50

    Wowra BStummer W: Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. J Neurosurg 97 (5 Suppl):4294322002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51

    Xu ZLee Vance MSchlesinger DSheehan JP: Hypopituitarism after stereotactic radiosurgery for pituitary adenomas. Neurosurgery 72:630–6376366372013

    • Crossref
    • Search Google Scholar
    • Export Citation

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 512 512 66
Full Text Views 89 89 6
PDF Downloads 66 66 4
EPUB Downloads 0 0 0

PubMed

Google Scholar